Toni Choueiri, Director of the Lank Center for Genitourinary Cancers and the Medical Director of Strategic International Initiatives at Dana-Farber Cancer Institute, shared a post by AACR on X/Twitter, adding:
“Looking forward to speak at this SABCS23 session about biomarkers of immunotherapy toxicity!
Thank you SABCS and AACR for the kind invite.”
Quoting AACR’s post:
“Immunotherapy: Purpose, Resistance, and Toxicity
Toni K. Choueiri, Valentina Hoyos Velez, Sherene Loi, and Kevin Litchfield will address this topic in a State-of-the-Art session at SABCS23. Learn more here.”
Source: Toni Choueiri/Twitter and AACR/Twitter